Effect of diet on the gut mycobiome and potential implications in inflammatory bowel disease

被引:2
|
作者
Buttar, J. [1 ]
Kon, E. [2 ,3 ]
Lee, A. [4 ]
Kaur, G. [2 ]
Lunken, G. [1 ,2 ,3 ]
机构
[1] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada
[3] BC Childrens Hosp Res Inst, Vancouver, BC, Canada
[4] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC, Canada
关键词
Gut; microbiome; mycobiome; diet; dietary modulation; inflammatory bowel disease; CANDIDA-ALBICANS; CROHNS-DISEASE; INTESTINAL MICROBIOTA; MAINTENANCE THERAPY; FUNGI; IMMUNITY; NUTRITION; INDUCTION; DIVERSITY; DYSBIOSIS;
D O I
10.1080/19490976.2024.2399360
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The gut microbiome is a complex, unique entity implicated in the prevention, pathogenesis, and progression of common gastrointestinal diseases. While largely dominated by bacterial populations, advanced sequencing techniques have identified co-inhabiting fungal communities, collectively referred to as the mycobiome. Early studies identified that gut inflammation is associated with altered microbial composition, known as gut dysbiosis. Altered microbial profiles are implicated in various pathological diseases, such as inflammatory bowel disease (IBD), though their role as a cause or consequence of systemic inflammation remains the subject of ongoing research. Diet plays a crucial role in the prevention and management of various diseases and is considered to be an essential regulator of systemic inflammation. This review compiles current literature on the impact of dietary modulation on the mycobiome, showing that dietary changes can alter the fungal architecture of the gut. Further research is required to understand the impact of diet on gut fungi, including the metabolic pathways and enzymes involved in fungal fermentation. Additionally, investigating whether dietary modulation of the gut mycobiome could be utilized as a therapy in IBD is essential.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] miRNA effects on gut homeostasis: therapeutic implications for inflammatory bowel disease
    Dhuppar, Shivnarayan
    Murugaiyan, Gopal
    TRENDS IN IMMUNOLOGY, 2022, 43 (11) : 917 - 931
  • [22] Diet in Inflammatory Bowel Disease
    Issa, Mazen
    Saeian, Kia
    NUTRITION IN CLINICAL PRACTICE, 2011, 26 (02) : 151 - 154
  • [23] Role of diet and gut microbiota in management of inflammatory bowel disease in an Asian migrant
    Kashyap, Purna C.
    Reigstad, Christopher S.
    Loftus, Edward V., Jr.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (01) : 250 - U421
  • [24] Gut microbiome as a potential biomarker of cancer risk in inflammatory bowel disease
    Jones, Ryan Lane
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (01): : 40 - 43
  • [25] The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
    Cammarota, Giovanni
    Ianiro, Gianluca
    Cianci, Rossella
    Sibbo, Stefano
    Gasbarrini, Antonio
    Curro, Diego
    PHARMACOLOGY & THERAPEUTICS, 2015, 149 : 191 - 212
  • [26] Gut permeability and inflammation in irritable bowel syndrome and inflammatory bowel disease: implications for pregnancy complications
    Sabra, Z.
    Kennedy, P. J.
    Moloney, G. M.
    Cryan, J. F.
    Dinan, T. G.
    Quigley, E. M. M.
    Khashan, A. S.
    Kenny, L. C.
    Clarke, G.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 : 27 - 28
  • [27] The gut microbiota and inflammatory bowel disease
    Goto, Yoshiyuki
    Kurashima, Yosuke
    Kiyono, Hiroshi
    CURRENT OPINION IN RHEUMATOLOGY, 2015, 27 (04) : 388 - 396
  • [28] The Gut Microbiota in Inflammatory Bowel Disease
    Sheehan, Donal
    Shanahan, Fergus
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2017, 46 (01) : 143 - +
  • [29] The gut microbiota and inflammatory bowel disease
    Matsuoka, Katsuyoshi
    Kanai, Takanori
    SEMINARS IN IMMUNOPATHOLOGY, 2015, 37 (01) : 47 - 55
  • [30] The Gut Microbiota in Inflammatory Bowel Disease
    Macfarlane, G. T.
    Blackett, K. L.
    Nakayama, T.
    Steed, H.
    Macfarlane, S.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (13) : 1528 - 1536